Can a smartphone app save mothers from preeclampsia in pakistan?
NCT ID NCT05662696
First seen Jun 01, 2026 · Last updated Jun 22, 2026 · Updated 7 times
Summary
This study is testing whether a mobile phone app can help pregnant women at high risk for preeclampsia in Karachi, Pakistan, monitor their blood pressure and symptoms at home. Fifty women will use the app to send daily readings to their healthcare team, who can then respond if needed. The goal is to see if this approach is practical and acceptable in a low-resource setting, not yet to prove it prevents complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jinnah Postgraduate Medical Centre
RECRUITINGKarachi, Sindh, 75510, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Raabta Telemonitoring Program (mobile application)
What this could lead to
If successful, this could show that a simple mobile app is a practical way to monitor high-risk pregnancies in low-resource settings, potentially reducing maternal deaths from preeclampsia.
What could go wrong
This is a very small, early feasibility study with only 50 participants in one city. It is not designed to prove the app prevents complications, only that it might be usable.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.